Literature DB >> 33391188

Asymmetric Graves' Orbitopathy.

Grigorios Panagiotou1, Petros Perros2.   

Abstract

Graves' Orbitopathy (GO) is an autoimmune orbital disorder usually presenting as a sequala of autoimmune thyroid disease. The presence of GO is associated with increased psychological burden and, in severe cases may cause blindness. While most patients with GO present with bilateral disease, asymmetric or unilateral GO may affect a significant proportion of patients diagnosed with GO. Older age, male sex, active and severe disease correlate with asymmetric disease. However, the exact mechanisms causing asymmetry remain elusive. Herein, we review the literature on asymmetric GO and highlight its differences compared with bilateral GO.
Copyright © 2020 Panagiotou and Perros.

Entities:  

Keywords:  Graves’ disease; asymmetry; exophthalmos; hyperthyroidism; unilateral

Mesh:

Year:  2020        PMID: 33391188      PMCID: PMC7774639          DOI: 10.3389/fendo.2020.611845

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  46 in total

1.  Death by Suicide in Graves' Disease and Graves' Orbitopathy: A Nationwide Danish Register Study.

Authors:  Charlotte Ferløv-Schwensen; Thomas Heiberg Brix; Laszlo Hegedüs
Journal:  Thyroid       Date:  2017-12       Impact factor: 6.568

2.  Normal values of hertel exophthalmometry in children, teenagers, and adults from Tehran, Iran.

Authors:  Mohsen Bahmani Kashkouli; Marzieh Nojomi; Mohammad Mehdi Parvaresh; Mostafa Soltan Sanjari; Mehdi Modarres; Mohammad Mehdi Noorani
Journal:  Optom Vis Sci       Date:  2008-10       Impact factor: 1.973

3.  Clinical features of thyroid-associated ophthalmopathy in clinically euthyroid Korean patients.

Authors:  S Y Jang; S Y Lee; E J Lee; J S Yoon
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

4.  An assessment of asymmetry in the normal craniofacial complex.

Authors:  S M Shah; M R Joshi
Journal:  Angle Orthod       Date:  1978-04       Impact factor: 2.079

5.  Selenium and the course of mild Graves' orbitopathy.

Authors:  Claudio Marcocci; George J Kahaly; Gerasimos E Krassas; Luigi Bartalena; Mark Prummel; Matthias Stahl; Maria Antonietta Altea; Marco Nardi; Susanne Pitz; Kostas Boboridis; Paolo Sivelli; George von Arx; Maarten P Mourits; Lelio Baldeschi; Walter Bencivelli; Wilmar Wiersinga
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245

6.  Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy.

Authors:  A K Eckstein; C Lösch; D Glowacka; M Schott; K Mann; J Esser; N G Morgenthaler
Journal:  Br J Ophthalmol       Date:  2009-02-15       Impact factor: 4.638

7.  Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.

Authors:  Mario Salvi; Guia Vannucchi; Irene Campi; Stefania Rossi; Paola Bonara; Francesco Sbrozzi; Claudio Guastella; Sabrina Avignone; Giacinta Pirola; Roberto Ratiglia; Paolo Beck-Peccoz
Journal:  Eur J Endocrinol       Date:  2006-04       Impact factor: 6.664

8.  Teprotumumab for the Treatment of Active Thyroid Eye Disease.

Authors:  Raymond S Douglas; George J Kahaly; Amy Patel; Saba Sile; Elizabeth H Z Thompson; Renee Perdok; James C Fleming; Brian T Fowler; Claudio Marcocci; Michele Marinò; Alessandro Antonelli; Roger Dailey; Gerald J Harris; Anja Eckstein; Jade Schiffman; Rosa Tang; Christine Nelson; Mario Salvi; Sara Wester; Jeffrey W Sherman; Thomas Vescio; Robert J Holt; Terry J Smith
Journal:  N Engl J Med       Date:  2020-01-23       Impact factor: 91.245

9.  3D-assisted quantitative assessment of orbital volume using an open-source software platform in a Taiwanese population.

Authors:  Victor Bong-Hang Shyu; Chung-En Hsu; Chih-Hao Chen; Chien-Tzung Chen
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

10.  Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study.

Authors:  P Perros; M P Žarković; G C Panagiotou; C Azzolini; G Ayvaz; L Baldeschi; L Bartalena; A M Boschi; M Nardi; T H Brix; D Covelli; C Daumerie; A K Eckstein; N Fichter; S Ćirić; L Hegedüs; G J Kahaly; O Konuk; J J Lareida; O E Okosieme; M Leo; L Mathiopoulou; L Clarke; F Menconi; D S Morris; J Orgiazzi; S Pitz; M Salvi; I Muller; M Knežević; W M Wiersinga; N Currò; C M Dayan; C Marcocci; M Marinò; L Möller; S H Pearce; F Törüner; M Bernard
Journal:  J Endocrinol Invest       Date:  2020-05-30       Impact factor: 4.256

View more
  2 in total

1.  3-D cephalometry of the the orbit regarding endocrine orbitopathy, exophthalmos, and sex.

Authors:  Konstantin Volker Hierl; Matthias Krause; Daniel Kruber; Ina Sterker
Journal:  PLoS One       Date:  2022-03-11       Impact factor: 3.240

2.  Thyroid eye disease with concurrent orbital lymphoma: a radiological surprise.

Authors:  Liza Das; Usha Singh; Bhanu Malhotra; Sanjay Kumar Bhadada; Pulkit Rastogi; Paramjeet Singh; Pinaki Dutta; Sameeksha Tadepalli
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2022-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.